๐ฐ Bionic Vision Technologies News
Bionic Vision Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bionic Vision Technologies. Real-time updates on events, politics, business and more.
December 2, 2023
/PRNewswire/ -- The artificial eye market size is expected to grow by USD 56.43 million from 2023 to 2028. In addition, the momentum of the market will...
September 26, 2022
/PRNewswire/ -- The artificial eye market is expected to grow by USD 34140.17 thousand at a CAGR of 8.16% during the forecast period of 2021-2026. Technavio...
June 30, 2022
Abercrombie, who was the consumer lenderโs chairman until last December and is its biggest shareholder, will take up the position once again after a tumultuous few months.
March 3, 2022
/PRNewswire/ -- The latest Artificial Retina market research report by Technavio infers that the rise in prevalence of retinal diseases is driving this...
March 3, 2022
/PRNewswire/ -- The latest Artificial Retina market research report by Technavio infers that the rise in prevalence of retinal diseases is driving this...
February 17, 2021
Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant News provided by Share this article Share this article MELBOURNE, Australia, Feb. 16, 2021 /PRNewswire/ -- Bionic Vision Technologies (BVT) has started work on the next phase of development for its world-leading Australian bionic eye technology thanks to a recent Australian Government grant to refine its vision processing algorithms. BVTs bionic eye is designed for people with the inherited...
January 13, 2021
The Fifth Annual Retina Fellow Summit This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 2.00 CME Activity Expiration Date: 12/31/2021 Activity Overview This activity features highlights captured from the Fifth Annual Retina Fellow Summit held in November 2020. The Summit included an expert faculty panel and an audience of retina fellows engaging in discussions on current clinical data, clinical cases, and practice transiti...